CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Humedix Co Ltd Company Snapshot
Humedix Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Humedix Co Ltd with three other companies in this sector in KOREA (SOUTH) : Hanall Biopharma Co Ltd (2020 sales of 88.60 billion Korean Won [US$78.68 million] of which 100% was Medical production and sales), JW Shinyak Corp (103.80 billion Korean Won [US$92.18 million] of which 100% was Medicine Manufacture and Sale), and PharmGen Science Inc (96.61 billion Korean Won [US$85.79 million] of which 100% was Pharmaceutical Segment).

Sales Analysis. Humedix Co Ltd reported sales of 98.48 billion Korean Won (US$87.45 million) for the year ending December of 2020. This represents an increase of 25.3% versus 2019, when the company's sales were 78.62 billion Korean Won . Sales at Humedix Co Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 134%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 89.7% in 2020, from 881.53 million Korean Won to 1.67 billion Korean Won . Humedix Co Ltd also saw significant increases in sales in Merchandise (up 88.4% to 19.78 billion Korean Won ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Humedix Co Ltd
  Stock Performance Chart for Humedix Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 38,850
(Figures in Korean Won )
1 Week 1.3%   13 Weeks 57.9%  
4 Weeks 87.7%   52 Weeks 94.7%  
 
Humedix Co Ltd Key Data:
  Ticker: 200670 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 98,480,868,087
(Year Ending Jan 2021).
Employees: 93
  Currency: Korean Won Market Cap: 365,328,111,750
  Fiscal Yr Ends: December Shares Outstanding: 9,403,555
  Share Type: Common Closely Held Shares: 4,229,134
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.